• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤红斑狼疮治疗的证据和成本综述。

A review of the evidence and cost of therapies for cutaneous lupus erythematosus.

机构信息

Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

出版信息

Lupus. 2019 Jun;28(7):799-805. doi: 10.1177/0961203319846397. Epub 2019 May 1.

DOI:10.1177/0961203319846397
PMID:31042129
Abstract

Cutaneous lupus erythematosus (CLE)-a common presentation of lupus erythematosus-may exist independently or as a part of the systemic manifestations of systemic lupus erythematosus. The effects of living with and treating a chronic condition such as CLE can be debilitating to a patient's health and finances. The management of patients with CLE is made particularly challenging by poor compliance, limited therapeutic options, scarcity of evidence supporting their use, and significant differences in costs of medications. Effective management of CLE should center on prevention, individualized treatment regimens, and a mutual understanding of the challenges that patients with CLE face. This article seeks to provide an overview of the efficacy, safety, and cost of therapeutic options for CLE.

摘要

盘状红斑狼疮(CLE)——红斑狼疮的常见表现——可能独立存在,也可能是系统性红斑狼疮全身表现的一部分。患有慢性疾病(如 CLE)并接受治疗会对患者的健康和经济状况产生严重影响。CLE 患者的依从性差、治疗选择有限、缺乏支持其使用的证据以及药物成本存在显著差异,这些因素使得 CLE 患者的管理极具挑战性。CLE 的有效管理应侧重于预防、个体化治疗方案以及对 CLE 患者所面临挑战的共同理解。本文旨在概述 CLE 的治疗选择的疗效、安全性和成本。

相似文献

1
A review of the evidence and cost of therapies for cutaneous lupus erythematosus.皮肤红斑狼疮治疗的证据和成本综述。
Lupus. 2019 Jun;28(7):799-805. doi: 10.1177/0961203319846397. Epub 2019 May 1.
2
Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review.当前治疗皮肤红斑狼疮的新理念和未来方法:全面综述。
Drugs. 2019 Jul;79(11):1199-1215. doi: 10.1007/s40265-019-01151-8.
3
Management of cutaneous manifestations of lupus erythematosus: A systematic review.红斑狼疮皮肤表现的治疗:系统评价。
Semin Arthritis Rheum. 2020 Feb;50(1):95-127. doi: 10.1016/j.semarthrit.2019.07.010. Epub 2019 Aug 12.
4
Treatment of cutaneous lupus.皮肤狼疮的治疗。
Curr Rheumatol Rep. 2011 Aug;13(4):300-7. doi: 10.1007/s11926-011-0180-z.
5
Novel biological therapeutic approaches to cutaneous lupus erythematosus.治疗红斑狼疮的新型生物疗法。
Expert Opin Biol Ther. 2018 Oct;18(10):1041-1047. doi: 10.1080/14712598.2018.1513484. Epub 2018 Sep 5.
6
Cutaneous lupus erythematosus: update of therapeutic options part I.皮肤红斑狼疮:治疗选择的更新部分 I。
J Am Acad Dermatol. 2011 Dec;65(6):e179-93. doi: 10.1016/j.jaad.2010.06.018. Epub 2010 Aug 23.
7
Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment.皮肤红斑狼疮:发病机制、诊断和治疗的最新进展。
Am J Clin Dermatol. 2016 Apr;17(2):135-46. doi: 10.1007/s40257-016-0173-9.
8
Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.在系统性红斑狼疮的更广泛背景下,推进对皮肤红斑狼疮的认识、诊断和治疗。
F1000Res. 2019 Mar 25;8. doi: 10.12688/f1000research.17787.1. eCollection 2019.
9
Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.治疗皮肤红斑狼疮的选择:最新进展和未来前景。
Expert Rev Clin Immunol. 2016 Oct;12(10):1109-21. doi: 10.1080/1744666X.2016.1188006. Epub 2016 Jun 1.
10
S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).欧洲皮肤病学论坛(EDF)与欧洲皮肤性病学会(EADV)合作制定的皮肤红斑狼疮治疗S2k指南。
J Eur Acad Dermatol Venereol. 2017 Mar;31(3):389-404. doi: 10.1111/jdv.14053. Epub 2016 Dec 20.

引用本文的文献

1
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll-Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study.Toll样受体7和8抑制剂阿菲美托兰在皮肤红斑狼疮患者中的安全性、耐受性、疗效、药代动力学及药效学:一项1b期随机、双盲、安慰剂对照研究
ACR Open Rheumatol. 2025 Jul;7(7):e70059. doi: 10.1002/acr2.70059.
2
Efficacy and safety of calcineurin inhibitors in cutaneous lupus: a systematic review and brief meta-analysis of recommended concentration, type, and outcomes.钙调神经磷酸酶抑制剂治疗皮肤型红斑狼疮的疗效与安全性:关于推荐浓度、类型及结局的系统评价与简要荟萃分析
Ann Med Surg (Lond). 2025 Mar 3;87(5):2880-2888. doi: 10.1097/MS9.0000000000003047. eCollection 2025 May.